content: <html>
  <head>
       <title></title>
  </head>
  <BODY STYLE="font-size: 10pt">
  
  <p style="margin: 0">&#160;&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>UNITED STATES</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>FORM 8-K</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>CURRENT REPORT</B></P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>Pursuant to Section 13 or 15(d) of the Securities
  Exchange Act of 1934</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center">Date of Report (Date of earliest event reported):
  February 13, 2017</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>GREENESTONE HEALTHCARE CORPORATION</B></P>
  
  <P STYLE="margin: 0; text-align: center">(Exact name of registrant as specified in its
  charter)</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Colorado</B></FONT></TD>
      <TD STYLE="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>000-15078</B></FONT></TD>
      <TD STYLE="width: 35%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>84-1227328</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                           or other jurisdiction of</FONT></P>
          <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation
          or organization)</FONT></P></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission
      File Number)</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
                                           Employer</FONT></P>
          <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
          No.)</FONT></P></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5734
                                           Yonge Street, Suite 300</B></FONT></P>
          <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Toronto,
          Ontario, Canada M2M 4E7</B></FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
      of principal executive offices)</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(416)
      222-5501</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&rsquo;s
      telephone number, including area code)</FONT></TD></TR>
  </TABLE>
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">Check the appropriate box below if the Form
  8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 3%; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">[
      ]</FONT></TD>
      <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="margin: 0; text-align: justify; width: 96%"><FONT STYLE="font-size: 10pt">Written communications pursuant to Rule
      425 under the Securities Act</FONT></TD></TR>
  </TABLE>
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 3%; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">[
      ]</FONT></TD>
      <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="margin: 0; text-align: justify; width: 96%"><FONT STYLE="font-size: 10pt">Soliciting material pursuant to Rule
      14a-12 under the Exchange Act</FONT></TD></TR>
  </TABLE>
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 3%; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">[
      ]</FONT></TD>
      <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="margin: 0; text-align: justify; width: 96%"><FONT STYLE="font-size: 10pt">Pre-commencement communications pursuant
      to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
  </TABLE>
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 3%; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">[
      ]</FONT></TD>
      <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="margin: 0; text-align: justify; width: 96%"><FONT STYLE="font-size: 10pt">Pre-commencement communications pursuant
      to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>
  
  <!-- Field: Page; Sequence: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"></P><P STYLE="margin-top: 0; margin-bottom: 0"></P></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>
  
  <P STYLE="margin: 0; text-align: justify"><B>Item 1.01</B><FONT STYLE="background-color: white">&nbsp;</FONT><B>Entry
  into a Material Definitive Agreement.</B></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><I>The
  Restructuring Transactions</I></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">On
  February 14, 2017, GreeneStone Healthcare Corporation, a Colorado corporation (&ldquo;GreeneStone&rdquo; or the &ldquo;Company&rdquo;)
  completed a series of transactions (referred to collectively as the &ldquo;Restructuring Transactions&rdquo;), including a share
  purchase agreement (the &ldquo;SPA&rdquo;) whereby GreeneStone acquired the stock of the company holding the Muskoka healthcare
  clinic real estate, an asset purchase agreement (the &ldquo;APA&rdquo;) and lease (the &ldquo;Lease&rdquo;) whereby the Company
  sold all of the Muskoka clinic business assets and leased the clinic building to the buyer, and a real estate purchase agreement
  and asset purchase agreement whereby GreeneStone purchased the real estate and business assets of a healthcare clinic in Florida
  (the &ldquo;Florida Purchase&rdquo;).</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><I>The
  Stock Purchase Agreement</I></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">Under
  the SPA, the Company acquired 100% of the stock of Cranberry Cove Holdings Ltd. (&ldquo;CCH&rdquo;) from Leon Developments Ltd.
  (&ldquo;Leon Developments&rdquo;), a company wholly owned by Shawn E. Leon, who is the President, CE, and CFO of GreeneStone (&ldquo;Mr.
  Leon&rdquo;). CCH owns the real estate on which the Company&rsquo;s rehabilitation clinic (&ldquo;the Canadian Rehab Clinic&rdquo;)
  in Muskoka, Ontario is located. The total consideration paid by GreeneStone was CDN$3,300,000 (an appraised value of CDN$10,000,000
  less the outstanding mortgage loan), which was funded by the assignment to Leon Developments of certain indebtedness owing to
  GreeneStone in the amount of CDN$659,918, and the issuance of 60,000,000 shares of the Company&rsquo;s common stock to Leon Developments,
  valued at approximately US$0.033 per share (the &ldquo;Shares&rdquo;).</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><I>The
  Asset Purchase Agreement and Lease</I></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">Under
  the APA, the assets of the Canadian Rehab Clinic were sold by GreeneStone, through its subsidiary, GreeneStone Clinic Muskoka
  Inc. (the &ldquo;Rehab Clinic Subsidiary&rdquo;), to Canadian Addiction Residential Treatment LP (the &ldquo;Purchaser&rdquo;),
  for a total consideration of CDN$10,000,000, plus an additional performance payment of up to CDN$3,000,000 performance payment
  to be received in 2019 if certain clinic performance metrics are met. The Purchaser completed the sale with cash proceeds to the
  Company of CDN$10,000,000, of which CDN$1,500,000.00 will remain in escrow for up to two years to cover indemnities given by the
  Company. Aside from using the proceeds of the Muskoka clinic asset sale to pay down significant tax debts and operational costs
  of the Company, the Company also used the proceeds to fund the Florida Purchase.</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">Through
  the APA, substantially all of the assets of the Rehab Clinic Subsidiary were sold, leaving GreeneStone with only the underlying
  clinic real estate, which GreeneStone through its newly acquired subsidiary CCH concurrently leased to the Purchaser. The Lease
  is a triple net lease and provides for a five (5) year primary term with three (3) five year renewal options, annual base rent
  for the first year at CDN$420,000 with annual increases, an option to tenant to purchase the leased premises and certain first
  refusal rights, all as set forth in the Lease filed herewith as Exhibit 10.3.</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><I>The
  Florida Purchase</I></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">Immediately
  after closing on the sale of its Muskoka clinic business, GreeneStone closed on the acquisition of the business and real estate
  assets of Seastone addiction treatment center in Delray Beach, Florida pursuant to certain real estate and asset purchase agreements
  described in and filed as exhibits to the May 17, 2016 Form 8K of the Company. This business will be operated through a newly
  formed Florida limited liability company named Seastone Delray Healthcare LLC. The purchase price for the Seastone assets was
  US$6,150,000 financed with a purchase money mortgage of US$3,000,000, a US$250,000 convertible promissory note from one of the
  sellers of the assets (the &ldquo;Note&rdquo;), and US$2,900,000 cash. </FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">The
  Note issued is in the principal amount of USD$250,000.00, bears a 0% interest rate and matures twenty-four (24) months from the
  date of issuance, on February 13, 2019, and gives the holder the right from time to time and at any time, to convert all or any
  part of the outstanding and unpaid principal amount of the Note into fully paid and non-assessable shares of the Company&rsquo;s
  common stock, subject to various other terms and conditions specified in the Note which is filed herewith as Exhibit 10.4. </FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">The
  foregoing description of the Restructuring Transactions does not purport to be complete and is qualified in its entirety by reference
  to the underlying agreements of the Restructuring Transactions, including the SPA, APA, Lease and Note, copies of which are attached
  hereto as Exhibits 10.1, 10.2, 10.3 and 10.4 respectively, and which are incorporated herein by reference. In addition, a copy
  of the Company&rsquo;s press release announcing the Restructuring Transactions is filed with this report as Exhibit 99.1, and
  is incorporated herein by reference.</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>Item
  2.01 Completion of Acquisition or Disposition of Assets</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">To
  the extent required by Item 2.01 of Form 8-K, the information contained in Item 1.01 of this report regarding the Restructuring
  Transactions is incorporated herein by reference.</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>Item
  2.03&nbsp;Creation of a Direct Financial Obligation.</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">The
  information provided in Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 2.03.</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>Item
  3.02</B>&nbsp;<B>Unregistered Sales of Equity Securities.</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">The
  applicable information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 3.02.
  </FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">The
  issuance of the Shares and the Note were done in connection with certain of the Restructuring Transactions and were not conducted
  in connection with a public offering, and no public solicitation or advertisement was made in connection with the issuances. </FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">The
  Shares and the Note were offered and issued without registration under the Securities Act of 1933, as amended (the &ldquo;Securities
  Act&rdquo;), in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act, as provided in Rule 506 of Regulation
  D promulgated thereunder, and in reliance on similar exemptions under applicable state laws. In acquiring the Note, the investor
  made representations to the Company that it met the accredited investor definition of Rule 501 of the Securities Act, and the
  Company relied on such representations. The Shares and the Note, and the shares of common stock issuable upon exercise of the
  conversion features of the Note, have not been registered under the Securities Act, or any other applicable securities laws, and
  unless so registered may not be offered or sold in the United States, except pursuant to an exemption from the registration requirements
  of the Securities Act.</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">This
  Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall such securities
  be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>Item&nbsp;9.01
  Financial Statements and Exhibits</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial
  Statements of Business Acquired</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>&#9;</B>The
  Company will file the financial statements required by Item 9.01(a) of Form 8-K by an amendment to this Form 8-K no later than
  71 days from the date this Form 8-K is required to be filed.</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pro
  Forma Financial Information</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">The
  Company will file the pro forma financial information required by Item 9.01(b) of Form 8-K by an amendment to this Form 8-K no
  later than 71 days from the date this Form 8-K is required to be filed.</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits.
  </B>The following exhibit is furnished with this report:</FONT></P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: white">
      <TD STYLE="width: 7%; font: 12pt Times New Roman, Times, Serif; text-align: left; text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit
      No.</U></FONT></TD>
      <TD STYLE="width: 93%; font: 12pt Times New Roman, Times, Serif; text-align: left; text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit
      Description</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="grst8l021617ex10_1.htm">Form of Stock Purchase Agreement, dated February 9, 2017</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt"><A HREF="grst8l021617ex10_2.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif">Form
      of Asset Purchase Agreement, dated February 13, 2017</FONT></A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD><FONT STYLE="font-size: 10pt">10.3</FONT></TD>
      <TD><FONT STYLE="font-size: 10pt"><A HREF="grst8l021617ex10_3.htm">Form of Lease dated February 13, 2017</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
      <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-size: 10pt">10.4</FONT></TD>
      <TD><FONT STYLE="font-size: 10pt"><A HREF="grst8l021617ex10_4.htm">Form of Note Dated February 13, 2016</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="grst8l021617ex99_1.htm">Press Release, dated February 14, 2017</A></FONT></TD></TR>
  </TABLE>
  
  <!-- Field: Page; Sequence: 2 -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="background-color: white"><B>SIGNATURES</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">Pursuant
  to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed
  on its behalf by the undersigned hereunto duly authorized.</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">Date:
  <B>February 17, 2017</B>&#9;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">By: /s/ Shawn E. Leon</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">Name: Shawn E. Leon</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"></FONT>Title: CEO</P>
  
  
  <!-- Field: Page; Sequence: 3 -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>EXHIBITS&nbsp;</B></FONT></P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white"><B>&nbsp;</B></FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; background-color: white"><TD STYLE="width: 7%; font: 12pt Times New Roman, Times, Serif; text-align: left; text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit
      No.</U></FONT></TD>
      <TD STYLE="width: 93%; font: 12pt Times New Roman, Times, Serif; text-align: left; text-decoration: underline"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Exhibit
      Description</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">10.1</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="grst8l021617ex10_1.htm">Form of Stock Purchase Agreement, dated February 9, 2017</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">10.2</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt"><A HREF="grst8l021617ex10_2.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif">Form
      of Asset Purchase Agreement, dated February 13, 2017</FONT></A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD><FONT STYLE="font-size: 10pt">10.3</FONT></TD>
      <TD><FONT STYLE="font-size: 10pt"><A HREF="grst8l021617ex10_3.htm">Form of Lease dated February 13, 2017</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
      <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-size: 10pt">10.4</FONT></TD>
      <TD><FONT STYLE="font-size: 10pt"><A HREF="grst8l021617ex10_4.htm">Form of Note Dated February 13, 2016</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">99.1</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="grst8l021617ex99_1.htm">Press Release, dated February 14, 2017</A></FONT></TD></TR></TABLE>
  
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  
  
  <P STYLE="margin: 0"></P>
  
  <!-- Field: Page; Sequence: 5; Options: Last -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"></P><P STYLE="margin-top: 0; margin-bottom: 0"></P></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin: 0"></p>
  
  </body>
  </html>
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "grst8l021617.htm", "secsgml_size_bytes": 33550}]
metadata_filer: {"company-data": {"conformed-name": "GREENESTONE HEALTHCARE CORP", "cik": "0000792935", "assigned-sic": "8062", "irs-number": "841227328", "state-of-incorporation": "CO", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-15078", "film-number": "17622343"}, "business-address": {"street1": "5734 YONGE ST.", "street2": "SUITE 300", "city": "TORONTO", "state": "A6", "zip": "M2M 4E7", "phone": "416-222-5501"}, "mail-address": {"street1": "5734 YONGE ST.", "street2": "SUITE 300", "city": "TORONTO", "state": "A6", "zip": "M2M 4E7"}, "former-company": {"former-conformed-name": "NOVA NATURAL RESOURCES CORP", "date-changed": "19920703"}}
text: UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION
  Washington, D.C. 20549
  FORM 8-K
  CURRENT REPORT
  Pursuant to Section 13 or 15(d) of the Securities
  Exchange Act of 1934
  Date of Report (Date of earliest event reported):
  February 13, 2017
  GREENESTONE HEALTHCARE CORPORATION
  (Exact name of registrant as specified in its
  charter)
  Colorado
  000-15078
  84-1227328
  (State
                                           or other jurisdiction of
  incorporation
          or organization)
  (Commission
      File Number)
  (IRS
                                           Employer
  Identification
          No.)
  5734
                                           Yonge Street, Suite 300
  Toronto,
          Ontario, Canada M2M 4E7
  (Address
      of principal executive offices)
  (416)
      222-5501
  (Registrant's
      telephone number, including area code)
  Check the appropriate box below if the Form
  8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
  [
      ]
  Written communications pursuant to Rule
      425 under the Securities Act
  [
      ]
  Soliciting material pursuant to Rule
      14a-12 under the Exchange Act
  [
      ]
  Pre-commencement communications pursuant
      to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  [
      ]
  Pre-commencement communications pursuant
      to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
  Item 1.01
  Entry
  into a Material Definitive Agreement.
  The
  Restructuring Transactions
  On
  February 14, 2017, GreeneStone Healthcare Corporation, a Colorado corporation ("GreeneStone" or the "Company")
  completed a series of transactions (referred to collectively as the "Restructuring Transactions"), including a share
  purchase agreement (the "SPA") whereby GreeneStone acquired the stock of the company holding the Muskoka healthcare
  clinic real estate, an asset purchase agreement (the "APA") and lease (the "Lease") whereby the Company
  sold all of the Muskoka clinic business assets and leased the clinic building to the buyer, and a real estate purchase agreement
  and asset purchase agreement whereby GreeneStone purchased the real estate and business assets of a healthcare clinic in Florida
  (the "Florida Purchase").
  The
  Stock Purchase Agreement
  Under
  the SPA, the Company acquired 100% of the stock of Cranberry Cove Holdings Ltd. ("CCH") from Leon Developments Ltd.
  ("Leon Developments"), a company wholly owned by Shawn E. Leon, who is the President, CE, and CFO of GreeneStone ("Mr.
  Leon"). CCH owns the real estate on which the Company's rehabilitation clinic ("the Canadian Rehab Clinic")
  in Muskoka, Ontario is located. The total consideration paid by GreeneStone was CDN$3,300,000 (an appraised value of CDN$10,000,000
  less the outstanding mortgage loan), which was funded by the assignment to Leon Developments of certain indebtedness owing to
  GreeneStone in the amount of CDN$659,918, and the issuance of 60,000,000 shares of the Company's common stock to Leon Developments,
  valued at approximately US$0.033 per share (the "Shares").
  The
  Asset Purchase Agreement and Lease
  Under
  the APA, the assets of the Canadian Rehab Clinic were sold by GreeneStone, through its subsidiary, GreeneStone Clinic Muskoka
  Inc. (the "Rehab Clinic Subsidiary"), to Canadian Addiction Residential Treatment LP (the "Purchaser"),
  for a total consideration of CDN$10,000,000, plus an additional performance payment of up to CDN$3,000,000 performance payment
  to be received in 2019 if certain clinic performance metrics are met. The Purchaser completed the sale with cash proceeds to the
  Company of CDN$10,000,000, of which CDN$1,500,000.00 will remain in escrow for up to two years to cover indemnities given by the
  Company. Aside from using the proceeds of the Muskoka clinic asset sale to pay down significant tax debts and operational costs
  of the Company, the Company also used the proceeds to fund the Florida Purchase.
  Through
  the APA, substantially all of the assets of the Rehab Clinic Subsidiary were sold, leaving GreeneStone with only the underlying
  clinic real estate, which GreeneStone through its newly acquired subsidiary CCH concurrently leased to the Purchaser. The Lease
  is a triple net lease and provides for a five (5) year primary term with three (3) five year renewal options, annual base rent
  for the first year at CDN$420,000 with annual increases, an option to tenant to purchase the leased premises and certain first
  refusal rights, all as set forth in the Lease filed herewith as Exhibit 10.3.
  The
  Florida Purchase
  Immediately
  after closing on the sale of its Muskoka clinic business, GreeneStone closed on the acquisition of the business and real estate
  assets of Seastone addiction treatment center in Delray Beach, Florida pursuant to certain real estate and asset purchase agreements
  described in and filed as exhibits to the May 17, 2016 Form 8K of the Company. This business will be operated through a newly
  formed Florida limited liability company named Seastone Delray Healthcare LLC. The purchase price for the Seastone assets was
  US$6,150,000 financed with a purchase money mortgage of US$3,000,000, a US$250,000 convertible promissory note from one of the
  sellers of the assets (the "Note"), and US$2,900,000 cash.
  The
  Note issued is in the principal amount of USD$250,000.00, bears a 0% interest rate and matures twenty-four (24) months from the
  date of issuance, on February 13, 2019, and gives the holder the right from time to time and at any time, to convert all or any
  part of the outstanding and unpaid principal amount of the Note into fully paid and non-assessable shares of the Company's
  common stock, subject to various other terms and conditions specified in the Note which is filed herewith as Exhibit 10.4.
  The
  foregoing description of the Restructuring Transactions does not purport to be complete and is qualified in its entirety by reference
  to the underlying agreements of the Restructuring Transactions, including the SPA, APA, Lease and Note, copies of which are attached
  hereto as Exhibits 10.1, 10.2, 10.3 and 10.4 respectively, and which are incorporated herein by reference. In addition, a copy
  of the Company's press release announcing the Restructuring Transactions is filed with this report as Exhibit 99.1, and
  is incorporated herein by reference.
  Item
  2.01 Completion of Acquisition or Disposition of Assets
  To
  the extent required by Item 2.01 of Form 8-K, the information contained in Item 1.01 of this report regarding the Restructuring
  Transactions is incorporated herein by reference.
  Item
  2.03 Creation of a Direct Financial Obligation.
  The
  information provided in Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 2.03.
  Item
  3.02
  Unregistered Sales of Equity Securities.
  The
  applicable information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 3.02.
  The
  issuance of the Shares and the Note were done in connection with certain of the Restructuring Transactions and were not conducted
  in connection with a public offering, and no public solicitation or advertisement was made in connection with the issuances.
  The
  Shares and the Note were offered and issued without registration under the Securities Act of 1933, as amended (the "Securities
  Act"), in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act, as provided in Rule 506 of Regulation
  D promulgated thereunder, and in reliance on similar exemptions under applicable state laws. In acquiring the Note, the investor
  made representations to the Company that it met the accredited investor definition of Rule 501 of the Securities Act, and the
  Company relied on such representations. The Shares and the Note, and the shares of common stock issuable upon exercise of the
  conversion features of the Note, have not been registered under the Securities Act, or any other applicable securities laws, and
  unless so registered may not be offered or sold in the United States, except pursuant to an exemption from the registration requirements
  of the Securities Act.
  This
  Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall such securities
  be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.
  Item 9.01
  Financial Statements and Exhibits
  (a)       Financial
  Statements of Business Acquired
  The
  Company will file the financial statements required by Item 9.01(a) of Form 8-K by an amendment to this Form 8-K no later than
  71 days from the date this Form 8-K is required to be filed.
  (b)       Pro
  Forma Financial Information
  The
  Company will file the pro forma financial information required by Item 9.01(b) of Form 8-K by an amendment to this Form 8-K no
  later than 71 days from the date this Form 8-K is required to be filed.
  (d)       Exhibits.
  The following exhibit is furnished with this report:
  Exhibit
      No.
  Exhibit
      Description
  10.1
  Form of Stock Purchase Agreement, dated February 9, 2017
  10.2
  Form
      of Asset Purchase Agreement, dated February 13, 2017
  10.3
  Form of Lease dated February 13, 2017
  10.4
  Form of Note Dated February 13, 2016
  99.1
  Press Release, dated February 14, 2017
  SIGNATURES
  Pursuant
  to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed
  on its behalf by the undersigned hereunto duly authorized.
  Date:
  February 17, 2017
  By: /s/ Shawn E. Leon
  Name: Shawn E. Leon
  Title: CEO
  EXHIBITS
  Exhibit
      No.
  Exhibit
      Description
  10.1
  Form of Stock Purchase Agreement, dated February 9, 2017
  10.2
  Form
      of Asset Purchase Agreement, dated February 13, 2017
  10.3
  Form of Lease dated February 13, 2017
  10.4
  Form of Note Dated February 13, 2016
  99.1
  Press Release, dated February 14, 2017